Q2 2017 Holdings
Filed 2018-03-02 | 60 holdings | $33.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc(AMGN) | COM | 031162100 | $8.6K | 50,104 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $9.8K | 77,475 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $11.8K | 96,641 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $17.5K | 135,522 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $23.1K | 177,522 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $23.6K | 48,130 | 0.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.9M | 37,000 | 5.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.8M | 137,773 | 11.5% |
| Biomarin Pharmaceuticals Inc(BMRN) | COM | 09061G101 | $10.7M | 118,166 | 32.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $16.6M | 61,108 | 49.8% |